← All organizations

Karos Pharmaceuticals

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Nov 1, 2015

Acquired by Roivant Sciences, Inc. → Sumitomo → Sumitomo Dainippon on Aug 9, 2017

Timeline

2000s

Jan 1, 2005
Sumitomo Dainippon— Now
Jun 1, 2009
Karos Pharmaceuticals— Founded

2010s

Aug 9, 2017
Roivant Sciences, Inc.— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 1 (1 own, 0 via acquisition)

rodatristat ethyl

Indications

Studied for

Hypertension

Recent trials (1)

NCT02746237Lead sponsorPhase 1Nov 1, 2015

Details

Founded: New Haven, CT, US Jun 1, 2009
Last known activity: Nov 1, 2015